DAVID ABIVA: Open Payments
NPI 1295858215 · WHITTIER, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,293 in 28 payments from 13 companies in 2025. Trend: 2023 $1,364 · 2024 $1,747 · 2025 $2,293
Food & beverage: $2,293
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 3 | $401 |
| AstraZeneca Pharmaceuticals LP | 3 | $359 |
| Novo Nordisk Inc | 8 | $225 |
| Madrigal Pharmaceuticals | 3 | $183 |
| Edwards Lifesciences Corporation | 1 | $169 |
| Axsome Therapeutics, Inc. | 2 | $147 |
| Otsuka America Pharmaceutical, Inc. | 1 | $143 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $141 |
| Phathom Pharmaceuticals, Inc. | 1 | $127 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $125 |
Products named: REPATHA, AIRSUPRA, REZDIFFRA, EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV), Ozempic, Symbravo, JARDIANCE, VOQUEZNA.
Industry payments across CA — which companies pay providers there.
